Dec 20, 2024
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
| Returns Type | 1 Month (%) | 6 Months (%) | 1 Year (%) | 3 Years (%) | 5 Years (%) | Since Inception (%) |
|---|---|---|---|---|
| Scheme - Tata India Pharma & Healthcare Fund (IDCW) RI | 4.59 | 17.7 | 42.34 | 22.77 |
| Benchmark - Nifty Pharma TRI | 3.37 | 15.62 | 40.52 | 20.43 |
| Category Average - BEST EQUITY PERFORMERS | 2.3 | 3.1 | 25.86 | 19.51 |
| Category Rank | 5/8 | 6/8 | 6/8 | 7/8 |
| Fund Name | Nav () | Chg (%) | 1Y Return(%) | 3Y Return(%) | 5Y Return(%) | AUM ( in Crs) | Exp. Ratio (%) | Min.Invst() | Action |
|---|---|---|---|---|---|---|---|---|---|
| Nippon India US Equity Opportunities Fund (G) | 33.9996 | 0.82 | 21.03 | 8.89 | 14.14 | 719.18 | 2.39 | 100.00 | invest |
| Nippon India US Equity Opportunities Fund (IDCW) | 33.9996 | 0.82 | 21.03 | 8.89 | 14.14 | 719.18 | 2.39 | 100.00 | invest |
| SBI Healthcare Opportunities Fund (G) | 429.2021 | 0.37 | 42.39 | 25.37 | 29.37 | 3,459.68 | 1.95 | 5,000.00 | invest |
| SBI Healthcare Opportunities Fund (IDCW) | 270.3752 | 0.37 | 42.39 | 25.37 | 29.37 | 3,459.68 | 1.95 | 5,000.00 | invest |
| Quant Teck Fund - Regular (G) | 13.3489 | -3.00 | 27.40 | 0.00 | 0.00 | 442.10 | 2.39 | 5,000.00 | invest |
| Company Name | As on Date | Invested Amt (Cr) | % Portfolio Weight | Change (%) (Invested Amt.) |
4 Months Trends |
|---|---|---|---|---|---|
| Equity-Sun Pharma.Inds. | Nov 30, 2024 | 143.24 | 11.80 | -3.68 |
|
| Equity-Aurobindo Pharma | Nov 30, 2024 | 93.56 | 7.71 | -9.59 |
|
| Equity-Lupin | Nov 30, 2024 | 84.13 | 6.93 | -6.23 |
|
| Equity-Cipla | Nov 30, 2024 | 75.16 | 6.19 | -1.15 |
|
| Equity-Dr Reddy`s Labs | Nov 30, 2024 | 73.89 | 6.09 | -5.64 |
|
| Equity-Divi`s Lab. | Nov 30, 2024 | 64.79 | 5.34 | 4.81 |
|
| Equity-Fortis Health. | Nov 30, 2024 | 56.37 | 4.64 | 5.52 |
|
| Net CA & Others-Net CA & Others | Nov 30, 2024 | 48.10 | 3.96 | -23.77 |
|
| Equity-Zydus Lifesci. | Nov 30, 2024 | 45.52 | 3.75 | -3.53 |
|
| Equity-Alkem Lab | Nov 30, 2024 | 42.46 | 3.50 | -2.37 |
|
Tata Mutual Fund has announced change in Fund Managers of the following sch...
Tata Mutual Fund has announced 04 December 2024 as the record date for decl...
Tata Asset Management has launched the Tata BSE Select Business Group Index...
Tata Mutual Fund has launched a new thematic fund, the Tata India Innovatio...
Tata Mutual Fund has announced 06 November 2024 as the record date for decl...
Tata Mutual Fund has announced the launch of the Tata Nifty Capital Markets...
| AMC Name | : | Tata Mutual Fund |
| Fund Name | : | Tata India Pharma & Healthcare Fund (IDCW) RI |
| Contact Persone | : | Meeta Shetty |
| Registered Address | : | 1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051 |
| Telephone No | : | 022 62827777 |
| Fax No. | : | 022 2261 3782. |
| : | service:tataamc.com | |
| Website | : | www.tatamutualfund.com |
Top Mutual Funds
